Congress Trades
Latest disclosures
| Chamber | Transaction Date | Member | Owner | Asset | Action | Amount | Ticker ▼ | Δ Since Trade |
|---|---|---|---|---|---|---|---|---|
| Senate | Nov. 20, 2020 | Thomas R. Carper | Spouse | Abbey Capital Futures Strategy Fund Class I | PURCHASE | $1,001 - $15,000 | ABYIX | — |
| Senate | Nov. 20, 2020 | Thomas R. Carper | Spouse | Abbey Capital Futures Strategy Fund Class I | PURCHASE | $1,001 - $15,000 | ABYIX | — |
| Senate | May. 16, 2022 | Thomas R. Carper | Spouse | Abbey Capital Futures Strategy Fund- Class I Sha | PURCHASE | $1,001 - $15,000 | ABYIX | — |
| Senate | Jul. 26, 2021 | Thomas R. Carper | Spouse | Abbey Capital Futures Strategy Fund- Class I Sha | PURCHASE | $1,001 - $15,000 | ABYIX | — |
| Senate | Dec. 11, 2024 | Markwayne Mullin | Joint | Abbott Laboratories Common Stock | SALE (PARTIAL) | $15,001 - $50,000 | ABT | ▲ +11.14% |
| Senate | Jan. 8, 2025 | Markwayne Mullin | Joint | Abbott Laboratories | SALE (FULL) | $1,001 - $15,000 | ABT | ▲ +11.03% |
| Senate | Sep. 21, 2023 | Pete Ricketts | Spouse | Abbott Laboratories | SALE | $100,001 - $250,000 | ABT | ▲ +28.22% |
| Senate | Apr. 9, 2019 | Tina Smith | Joint | Abbott Laboratories | SALE (FULL) | $250,001 - $500,000 | ABT | ▲ +61.24% |
| House | Jan. 6, 2025 | Emily Randall | Spouse | Abbott Laboratories | SALE | $1,001 - $15,000 | ABT | ▲ +12.22% |
| House | Jul. 29, 2024 | Josh Gottheimer | Joint | Abbott Laboratories Common Stock | PURCHASE | $1,001 - $15,000 | ABT | ▲ +21.07% |
| House | Jul. 18, 2025 | Josh Gottheimer | Joint | Abbott Laboratories | SALE | $1,001 - $15,000 | ABT | ▲ +2.57% |
| House | Mar. 15, 2023 | Rich McCormick | Abbott Laboratories | PURCHASE | $1,001 - $15,000 | ABT | ▲ +29.70% | |
| Senate | Apr. 24, 2018 | Shelley Moore Capito | Spouse | Abbott Laboratories | PURCHASE | $1,001 - $15,000 | ABT | ▲ +117.54% |
| House | Oct. 6, 2025 | Rick Larsen | Abbott Laboratories | PURCHASE | $1,001 - $15,000 | ABT | ▼ -5.15% | |
| House | Aug. 14, 2025 | Julie Johnson | Joint | Abbott Laboratories | SALE | $1,001 - $15,000 | ABT | ▼ -1.88% |
| House | Jul. 23, 2024 | Thomas H. Kean | Abbott Laboratories Common Stock | PURCHASE | $1,001 - $15,000 | ABT | ▲ +22.07% | |
| House | Jul. 5, 2024 | Jared Moskowitz | Abbott Laboratories Common Stock | PURCHASE | $1,001 - $15,000 | ABT | ▲ +21.95% | |
| Senate | Feb. 24, 2025 | Shelley Moore Capito | Spouse | Abbott Laboratories | SALE (PARTIAL) | $1,001 - $15,000 | ABT | ▼ -6.00% |
| Senate | Oct. 3, 2023 | Markwayne Mullin | Joint | Abbott Laboratories Common Stock | PURCHASE | $1,001 - $15,000 | ABT | ▲ +32.43% |
| Senate | Sep. 13, 2023 | Markwayne Mullin | Joint | Abbott Laboratories Common Stock | PURCHASE | $15,001 - $50,000 | ABT | ▲ +23.53% |
| Senate | Jan. 17, 2024 | Thomas R. Carper | Spouse | Abbott Laboratories | SALE (PARTIAL) | $1,001 - $15,000 | ABT | ▲ +11.34% |
| Senate | Oct. 17, 2022 | Thomas R. Carper | Spouse | Abbott Laboratories Common Stock | PURCHASE | $1,001 - $15,000 | ABT | ▲ +22.54% |
| Senate | Oct. 24, 2017 | Bill Cassidy | Spouse | Abbott Laboratories | SALE (PARTIAL) | $1,001 - $15,000 | ABT | ▲ +129.05% |
| Senate | Mar. 3, 2020 | Shelley Moore Capito | Spouse | Abbott Laboratories | PURCHASE | $1,001 - $15,000 | ABT | ▲ +62.65% |
| House | Sep. 4, 2024 | John James | Abbott Laboratories Common Stock | SALE (FULL) | $1,001 - $15,000 | ABT | ▲ +10.88% | |
| House | Feb. 13, 2024 | Jared Moskowitz | Abbott Laboratories Common Stock | SALE (FULL) | $1,001 - $15,000 | ABT | ▲ +13.93% | |
| House | Jul. 2, 2024 | Kathy Manning | Spouse | Abbott Laboratories Common Stock | PURCHASE | $1,001 - $15,000 | ABT | ▲ +22.92% |
| Senate | Apr. 24, 2018 | Shelley Moore Capito | Spouse | Abbott Laboratories | PURCHASE | $1,001 - $15,000 | ABT | ▲ +117.54% |
| House | Jul. 10, 2025 | Lisa McClain | Spouse | Abbott Laboratories | SALE | $1,001 - $15,000 | ABT | ▼ -5.05% |
| House | Jun. 24, 2025 | Lisa McClain | Spouse | Abbott Laboratories Common Stock | PURCHASE | $1,001 - $15,000 | ABT | ▼ -8.13% |
Last updated: Oct 25, 06:30